Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial - Brown, JP; Prince, RL; Deal, C (J Bone Miner Res, 2009)
et al.